Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.47 |
| ▸ | HPGDS | O60760 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25888855 | 1.00 | GPR119 (0.47) | GPR119HPGDSKDM4EPDE10ANR1H2 | |
| SCHEMBL25888789 | 0.86 | GPR119 (0.44) | GPR119HPGDSKDM4EPDE10A | |
| SCHEMBL31654410 | 0.86 | GPR119 (0.44) | GPR119HPGDSKDM4EPDE10A | |
| SCHEMBL25888707 | 0.82 | GPR119 (0.43) | GPR119HPGDSKDM4ENR1H2JAK3 | |
| SCHEMBL25888625 | 0.79 | EGLN2 (0.44) | GPR119 | |
| SCHEMBL31654820 | 0.79 | EGLN2 (0.44) | GPR119 | |
| SCHEMBL25307351 | 0.77 | GPR119 (0.41) | GPR119KDM4E | |
| SCHEMBL30527693 | 0.77 | GPR119 (0.41) | GPR119KDM4E | |
| SCHEMBL31654465 | 0.77 | PDE10A (0.47) | GPR119KDM4EPDE10ANR1H2JAK3 | |
| SCHEMBL25888854 | 0.77 | PDE10A (0.47) | GPR119KDM4EPDE10ANR1H2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215029-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. | 2025-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215029-A1 | STAT MODULATORS AND USES THEREOF | STAT6, STAT3, STAT5A | GPR119 399/4885HPGDS 637/4885KDM4E 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.